Anthony B. Evnin's most recent trade in Infinity Pharmaceuticals Inc. was a trade of 46,378 Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on June 16, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Infinity Pharmaceuticals Inc. | Anthony B. Evnin | Director | Grant, award, or other acquisition of securities at price $ 0.68 per share. | 16 Jun 2022 | 46,378 | 215,403 (0%) | 0% | 0.7 | 31,491 | Common Stock |
| Infinity Pharmaceuticals Inc. | Anthony B. Evnin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option(right to buy) | |
| Infinity Pharmaceuticals Inc. | Anthony B. Evnin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Infinity Pharmaceuticals Inc. | Anthony B. Evnin | Director | Grant, award, or other acquisition of securities at price $ 3.43 per share. | 10 Jun 2021 | 3,061 | 169,025 (0%) | 0% | 3.4 | 10,499 | Common Stock |